tirzepatide journal club SUMMIT: Improves Outcomes and Quality of Life For Patients With HFpEF and Obesity In the SURMOUNT-1 trial (published
Description
Because insurers refuse to cover medications that are not FDA-approved
Triethylamine (0.2%) was added to the peptide:fatty acid solution (1:4) and incubated at 4 C for 1 h

You sometimes need a baseline BMI of at least 30 kilograms per meters squared (kg/m2)

Iwai T, Suzuki M, Kobayashi K, Mori K, Mogi Y, Oka JI
Only unbound drug is pharmacologically active, so the albumin-bound reservoir acts as a slow-release mechanism that maintains therapeutic levels between weekly doses

The timing of symptom onset postinjection and resolution without intervention other than a change in injection site suggested a drug-related cause
